Gene: TAGLN3
Official Full Name: transgelin 3provided by HGNC
Gene Summary: Predicted to enable actin filament binding activity. Predicted to be involved in actin filament organization. Predicted to act upstream of or within negative regulation of transcription by RNA polymerase II. Predicted to be located in nucleus. Predicted to be active in actin cytoskeleton and synapse. [provided by Alliance of Genome Resources, Apr 2025]
| Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
|---|---|---|---|---|---|---|
| KOA09866 | TAGLN3 Knockout cell line (AC16) | Human | TAGLN3 | 1:3-1:4 | negative | Online Inquiry |
| KOA25310 | TAGLN3 Knockout cell line (BEAS-2B) | Human | TAGLN3 | 1:3~1:4 | negative | Online Inquiry |
| KOA40759 | TAGLN3 Knockout cell line (U-2932) | Human | TAGLN3 | 1:2-1:4 | negative | Online Inquiry |
| KOA56143 | TAGLN3 Knockout cell line (TPC-1) | Human | TAGLN3 | 1:5-1:8 | negative | Online Inquiry |
| KOA71561 | TAGLN3 Knockout cell line (NCM460) | Human | TAGLN3 | 1:2~1:3 | negative | Online Inquiry |
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.